rs398123724
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PM5PP3_ModeratePP5
The NM_003482.4(KMT2D):c.15142C>T(p.Arg5048Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R5048H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003482.4 missense
Scores
Clinical Significance
Conservation
Publications
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome  AF:  6.84e-7  AC: 1AN: 1461042Hom.:  0  Cov.: 33 AF XY:  0.00  AC XY: 0AN XY: 726656 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Kabuki syndrome 1    Pathogenic:4 
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as disease-causing [PMID 21671394, 27302555, 25972376] -
PS2, PS4, PM2, PP3 -
- -
- -
not provided    Pathogenic:2Uncertain:1 
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in a patients with Kabuki syndrome in published literature (Hannibal et al., 2011; Bogershausen et al., 2016); This variant is associated with the following publications: (PMID: 27302555, 30459467, 23913813, 19625956, 23320472, 22126750, 30176882, 29682684, 25972376, 28404210, 21671394, 29089047) -
- -
Kabuki syndrome    Pathogenic:1 
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably damaging"; Align-GVGD: "Class C0"). This variant has been reported in multiple individuals affected with Kabuki syndrome including at least 5 individuals in whom the variant have been confirmed to be de novo (PMID: 21671394, 27302555, 25972376, 23913813). It has also been found in a mother and daughter with Kabuki syndrome (PMID: 19625956, 22126750). ClinVar contains an entry for this variant (Variation ID: 94180). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with cysteine at codon 5048 of the KMT2D protein (p.Arg5048Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. -
Inborn genetic diseases    Pathogenic:1 
The c.15142C>T (p.R5048C) alteration is located in exon 48 (coding exon 48) of the KMT2D gene. This alteration results from a C to T substitution at nucleotide position 15142, causing the arginine (R) at amino acid position 5048 to be replaced by a cysteine (C). Based on data from the Genome Aggregation Database (gnomAD), the KMT2D c.15142C>T alteration was not observed, with coverage at this position. This mutation was identified in multiple individuals with Kabuki syndrome (Hannibal, 2011; Banka, 2012; Makrythanasis, 2013; Van Laarhoven, 2015), including one de novo case (Miyake, 2013). The p.R5048C alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at